Richard A. Heyman - 11 May 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Role
Director
Signature
/s/ Dominic Piscitelli, attorney-in-fact
Issuer symbol
ORIC
Transactions as of
11 May 2021
Net transactions value
-$2,511
Form type
4
Filing time
13 May 2021, 20:00:31 UTC
Next filing
23 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORIC Common Stock Sale $2,511 -100 -0.04% $25.11 227,100 11 May 2021 See footnote F1, F2
holding ORIC Common Stock 12,500 11 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by RAHD Capital, LLC.
F2 The shares are held of record by RAHD Capital, LLC, and the Reporting Person has voting and investment power with respect to such shares.